BeiGene Stock Went Up By Over 10% So Far Today
BeiGene, a renowned pharmaceutical company specializing in oncology medications, witnessed a sudden upsurge in its stock prices on Thursday. After suffering losses for three consecutive trading sessions, the company’s stock surged by 10.3%, contrasting with NASDAQ’s loss of 0.12%. This brief introduction paves the way to explore more about BeiGene’s stock market performance and its…